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ABSTRACT 
 
The endoplasmic reticulum (ER) is a highly organized organelle that performs vital 
functions including de novo membrane lipid synthesis and transport. Accordingly, numerous 
lipid biosynthesis enzymes are localized in the ER membrane. However, it is now evident 
that lipid metabolism is sub-compartmentalized within the ER and that lipid biosynthetic 
enzymes engage with lipid transfer proteins (LTPs) to rapidly shuttle newly synthesized lipids 
from the ER to other organelles. As such, intimate relationships between lipid metabolism 
and lipid transfer pathways exist within the ER network. Notably, certain LTPs enhance the 
activities of lipid metabolizing enzymes; likewise, lipid metabolism can ensure the specificity 
of LTP transfer/exchange reactions. Yet, our understanding of these mutual relationships is 
still emerging. Here, we highlight past and recent key findings on specialized ER membrane 
domains involved in efficient lipid metabolism and transport and consider unresolved issues 
in the field. This article is part of a Special Issue entitled: ER Platforms for Membrane Lipid 
Dynamics edited by Shamshad Cockcroft and Christopher J. Stefan. 
 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 3 
1. Introduction 
The endoplasmic reticulum (ER) is a vast membrane compartment that extends from 
the nuclear envelope (NE) to cytoplasmic ER sheets and peripheral ER tubules [1]. While the 
ER network is continuous, it is arranged into distinct morphological and functional domains. 
Historically, ER sheets and tubules have been described as ribosome-studded rough ER and 
ribosome-free smooth ER, respectively [2, 3]. The rough ER has dedicated roles in protein 
translocation, quality control, and secretion. In contrast, vital functions for the smooth ER are 
quite diverse including calcium homeostasis [4] as well as the metabolism of membrane 
lipids [5], steroid hormones, and even toxic substances [6, 7]. To carry out these essential 
activities as needed, smooth ER cisternae and tubules are continuously formed and remodeled. 
Accordingly, an elegant electron tomography study has revealed a complex meshwork of 
peripheral ER cisternae and tubules in budding yeast cells [8]. Another recent study using 
super-resolution microscopy on mammalian cells has suggested that cortical ER structures 
that are closely apposed to the PM consist of packed ER tubules that form a dense matrix [9]. 
Thus, the ER consists of a diverse membrane network where specialized functions are 
partitioned into different structural regions. 
In addition to a variety of shapes, the ER forms an elaborate system of interactions 
with other organelles termed membrane contact sites [10-15]. A growing number of studies 
have described important roles for membrane contact sites including lipid exchange and 
transfer [16-19]. Contact sites are thought to provide an optimal environment for non-
vesicular lipid transport by maintaining a short distance (less than 30 nm) between different 
organelle compartments. Moreover, as first shown in seminal biochemical experiments, ER 
membranes associated with other compartments, such as mitochondria and the plasma 
membrane, are highly enriched in their capacity to synthesize phospholipids and sterols [20-
23]. Taken together, these findings indicate that lipid metabolism and transport are closely 
coupled at ER-organelle contact sites. Here we review key discoveries and recent findings on 
how the ER membrane is organized to achieve efficient lipid metabolism and non-vesicular 
transport and how these two processes undergo mutual cross talk to promote one another. 
 
2. Compartmentalization of phospholipid biosynthesizing enzymes in the ER  
It is well known that most phospholipids are synthesized in the ER [5] (Fig. 1). 
However, pioneering cell fractionation experiments suggested that lipid synthesis is enriched 
at specialized ER subdomains associated with other organelles such as mitochondria. 
Accordingly, with advances in live cell imaging techniques, a heterogeneous distribution of 
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phospholipid biosynthesizing enzymes (but not all) within the ER has recently emerged. In 
many cases, this occurs at membrane contact sites where lipid transfer proteins can deliver 
newly synthesized lipids to other organelles for membrane expansion and homeostasis (Fig. 
2). In this section, we highlight examples of phospholipid biosynthetic activities that display 
enriched activity within subdomains of the ER.  
 
2.1. Phosphatidylserine (PS) synthase 
One of the first studies providing compelling evidence for compartmentalization of 
phospholipid biosynthesis within the ER was performed by Dr. Jean E. Vance [20]. A 
microsomal ER fraction associated with mitochondria (called MAM, mitochondrial-
associated ER membranes) purified from rat liver showed high activity for 
phosphatidylserine (PS), phosphatidylethanolamine (PE), and phosphatidylcholine (PC) 
synthesis from serine [20] (Figs. 1 and 2). Contacts between the ER and mitochondria were 
first observed in hepatocytes by electron microscopy in 1952 by Bernhard and colleagues 
[24]. A few years later, Bernhard and Rouiller speculated that ER-mitochondrial contacts 
might have vital roles in ER physiology [25]. However, a clearly defined role for this 
association remained elusive until Vance’s biochemical studies decades later, revealing that 
ER-mitochondrial contacts are enriched in phospholipid biosynthetic activities (Figs. 1 and 2). 
Among them, the synthesis of PS at MAMs has been extensively analyzed [11]. In mammals, 
PS is synthesized by a base-exchange reaction from PC by PSS-1 or PE by PSS-2 (Fig. 1). 
Both PSS-1 and PSS-2 are enriched in the MAM fraction [21]. Activity of the yeast PS 
synthase, the Cho1 protein that generates PS from CDP-diacylglycerol (Fig. 1), is also 
enriched in MAM fractions [23]. Thus, an enrichment of PS synthase activity in MAM 
fractions is conserved in yeast and mammals in spite of the fact that PS is generated via 
different catalytic mechanisms in these species (Figs. 1 and 2). In yeast, PS synthase activity 
is also enriched in ER fractions associated with the plasma membrane (PM) called PAM, PM-
associated ER membranes [22]. Based on these evidences, PS synthase activity is enriched at 
ER-mitochondria contacts and also at ER-PM contacts (Fig. 2). Robust PS synthase activity 
at membrane contact sites is likely to be supported by PS transfer proteins that function at 
these sites, as PS synthase is subject to product feedback inhibition in the ER (discussed in 
greater detail in Sections 3 and 4 below). 
 
2.2. Cholinephosphotransferase (CPT) and ethanolaminephosphotransferase (EPT)   
  Most eukaryotic cells synthesize PC and PE via the CDP-choline and CDP-
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ethanolamine pathways by cholinephosphotransferase (CPT) and 
ethanolaminephosphotransferase (EPT), respectively (Fig. 1). Biochemical fractionation 
analyses have shown that both CPT and EPT activities are detected mainly in microsomal ER 
fractions isolated from rat liver [26, 27]. In mammals, the CPT and EPT reactions are also 
catalyzed by CEPT1, a dual specificity choline/ethanolaminephosphotransferase [28] that is 
localized to the ER [29]. Interestingly, enrichment of CEPT1 at the tips of growing ER 
tubules in COS-7 has been reported [30]. Thus, do novo phospholipid synthesis via CEPT1 
may drive the dynamic organization of the reticular ER network. 
 
2.3. Phosphatidylethanolamine N-methyltransferase (PEMT) 
Conversion of PE to PC is catalyzed by the enzyme PEMT (PE methyltransferase) in 
hepatocytes and by Cho2 and Opi3 in yeast via a process known as the methylation pathway 
(Fig. 1). PEMT activity is enriched in MAM fractions isolated from rat liver and PEMT 
appears to localize to MAM domains by microscopic analysis in sections from rat liver tissue 
[31]. In yeast cells, the majority of PC is generated by PEMTs [5]. Yeast PEMT enzymatic 
activities (carried out by the Cho2 and Opi3 proteins) are also readily detected in MAM 
fractions, while the proteins themselves may not be necessarily enriched at MAMs [23]. 
Another study reported that Opi3 is localized at peripheral ER structures associated with the 
PM where it may convert PE to PC in trans [32].  
 
2.4. Phosphatidylinositol (PI) synthase   
Phosphatidylinositol (PI) is generated from CDP-diacylglycerol by PI synthase (PIS) 
(Fig. 1). The site of PI synthesis has been under debate for a long time. Biochemical analyses 
have shown that PIS activity is found mainly in microsomal ER fractions derived from rat 
liver [33, 34], while PM fractions were also reported to have high PIS activity under different 
experimental conditions [35, 36]. In addition, PIS activity has also been detected in Golgi 
compartment fractions derived from rat liver and yeast [26, 37]. A study has even suggested 
that PIS is enriched in highly mobile ER-derived compartments in intact COS-7 cells [38]. 
These mobile PIS compartments transiently contact other organelle membranes [38]. Another 
study has shown that PIS-enriched assemblies are mainly formed at the leading edge of 
dynamic ER tubules in COS-7 cells. These structures also contain the phospholipid 
biosynthesizing enzyme CEPT1 (Fig. 1) [30]. Similar PIS assemblies in the ER have been 
confirmed in other cell lines (HeLa and RPE cells) [39, 40] suggesting that PIS is most likely 
present in specialized ER subdomains. Given that PIS activity is enriched in MAM and PAM 
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fractions derived from yeast cells [22, 23], the punctate PIS structures could reflect 
localization at membrane contact sites between the ER and other compartments. Localization 
to PAM fractions may play an important role in the synthesis of phosphoinositide lipids at the 
PM, as discussed by other review articles by the Balla and Cockcroft groups in this issue [41, 
42]. 
The involvement of PIS-enriched domains in autophagosome formation has been 
also reported [43]. Under starvation conditions, various autophagy-related (ATG) proteins are 
sequentially recruited to the ER membrane to induce autophagosome formation in 
mammalian cells. In spite of the fact that ATG proteins associate with the ER membrane at an 
early stage of autophagy, they do not show a typical reticular ER distribution. Instead they 
form a punctate structure at the ER, implying the existence of an ER subdomain required for 
autopahgosome formation. Interestingly, the ATG protein assemblies are recruited to a PIS-
enriched ER subdomain to initiate autophagosome formation [43]. As phosphatidylinositol 3-
phosphate (PI3P) formation is a critical step for autophagosome formation, the PIS-enriched 
domain might be involved in PI3P metabolism at ER-isolation membrane contact sites [44]. 
 
3. Phospholipid transfer between the ER and other compartments by lipid transfer 
proteins (LTPs) 
Newly synthesized lipids in the ER are delivered to their final destination via 
vesicular and non-vesicular mechanisms (see a review article by Drs. Funato, Riezman and 
Muñiz in this issue) [45]. However, bulk lipid transport is thought to occur in a non-vesicular 
fashion via lipid transfer proteins (LTPs). In general, LTPs have cytoplasmic domains bearing 
hydrophobic cavities that extract and exchange lipid molecules between membranes. Many 
proteins belong to lipid transfer protein families based on sequence homology; however 
which LTPs transport which lipids in vivo has been less clear. Several recent studies have 
revealed physiological ligands of LTPs and proposed models for lipid exchange and transport. 
In this section, we briefly summarize recent progress on phospholipid transfer proteins. 
Several other excellent reviews provide a comprehensive review of LTPs and transport of 
other lipids including sterols [16, 18, 46]. 
 
3.1. Class I PITPs 
The first phosphatidylinositol transfer protein (PITP) was purified from bovine brain and 
shown to bind, exchange, and transfer phospholipids in vitro, in particular PI and PC [47]. In 
mammals, there are five PITP proteins that are categorized into Class I and II based on 
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sequence differences [48]. Class I PITPs (PITP and PITP) consist only of a PITP domain 
and have dual ligand binding specificity for PI and PC [47, 49]. Accordingly, PITP and 
PITP efficiently transfer PI or PC between membranes in vitro [50]. The crystal structures 
of PITP and PITPreveal a hydrophobic pocket that can accommodate a single 
phospholipid molecule, either PI or PC [51-54]. Structural analysis of PITP bound to PI has 
shown that four residues (Thr-59, Lys-61, Glu-86 and Asn-90) are critical for PI binding, but 
not PC binding[52]. In contrast, the Cys-95 residue in the head group binding pocket of 
PITP is required for PC binding [55] Given that these residues are conserved in both PITP 
and PITP [52, 55], it is proposed that PI/PC exchange or transfer is the common function of 
Class I PITPs. In one model, it has been suggested that PITP transfers PI from the ER to the 
cis-Golgi compartments to facilitate phosphatidylinositol 4-phosphate (PI4P) synthesis by PI 
4-kinase [55]. At ER-PM contacts (PAM), PI exchange or transfer by Class I PITPs has been 
implicated in phospholipase C and EGF receptor signaling by promoting phosphoinositide 
kinase activities [56, 57]. However, strong arguments have proposed that Class I PITP lipid 
exchange activity (rather than lipid transfer per se) suffices for PI 4-kinase activity in vivo 
[58]. Thus, whether Class I PITPs function as PI transfer proteins or as PI exchange proteins 
in vivo remains an issue that is currently still under debate. 
 
3.2. Class II PITPs 
Class II PITPs include PITPNM1/RdgBI/Nir2, PITPNM2/RdgBII/Nir3 and 
PITPNC1/RdgB The name RdgB is derived from retinal degeneration type B describing the 
phenotype manifested in Drosophila lacking a functional RdgB protein [59]. Mammalian 
RdgBI/Nir2 (Class II), but not mammalian PITP(Class I), rescues the fly RdgB mutant 
indicating that Class I and II PITPs are functionally different [60]. A recent study has shown 
that, unlike Class I PITPs, Class II PITPs have the ability to bind phosphatidic acid, PA, 
instead of PC [61]. Consistent with this observation, Cys-95, a key residue for PC binding in 
PITP, is replaced with threonine in Class II PITPs [61]. Thus, Class II PITPs mainly 
exchange or transfer PI and PA, not PC. As such, Class II PITPs serve as key factors at ER-
PM contacts (PAM) during phospholipase C signaling and the phosphoinositide cycle (see 
two review articles by the Balla and Cockcroft groups in this issue) [41, 42]. Indeed, several 
studies have shown that Class II PITPs (Nir2, Nir3 and Drosophila RdgB) enhance 
phosphatidylinositol 4,5-bisphosphate, PI(4,5)P2, re-synthesis by exchanging PI/PA at ER-
PM contact sites in vivo [62-66]. 
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3.3. Sec14/CRAL-TRIO domain family 
Sec14 is the prototype of the Sec14 domain (also referred to as the CRAL-TRIO 
domain) superfamily, as it was first characterized as a PI/PC exchange protein essential for 
Golgi secretory function and cell viability in yeast [67-70]. Yeast mutant cells lacking Sec14 
function can be rescued by overexpression of mammalian PITPs [71, 72]. Moreover, Sec14 
and mammalian Class I PITPs show a common function for PI/PC exchange in permeabilized 
cells [73] in spite of the fact that Sec14 has no sequence or structural homology to 
mammalian PITPs. Based on genetic and biochemical evidence [74-76], it is proposed that 
Sec14 coordinates PC and PI4P metabolic pathways with Golgi network organization and 
function. Crystal structures of Sec14 and Sfh1 (the closest Sec14 homolog) demonstrate that 
the Sec14/CRAL-TRIO domain forms a hydrophobic pocket that is occupied by one 
phospholipid molecule [77-79]. Both PI and PC binding activities of Sec14 are essential for 
cell growth and stimulation of PI4P synthesis in yeast [77]. Curiously, some mammalian 
Sec14-related proteins bind other hydrophobic ligands such as 11-cis-retinol, -tocopherol, 
or squalene with high affinity rather than PI in vitro [80]. While it is unclear whether all 
mammalian Sec14 family members carry out phospholipid exchange, the Sec14-like domain 
of neurofibromin/NF1 can harbor a phospholipid molecule in vitro [80-82]. Future studies are 
needed to determine whether mammalian Sec14-like isoforms have a conserved role in the 
control of PI4P synthesis as PI exchange proteins. 
 
3.4.1. ORP/Osh protein family 
Oxysterol binding protein (OSBP) was originally identified as a cytosolic protein 
that strongly binds 25-hydroxycholesterol [83, 84]. Based on sequence homology, >12 
OSBP-related proteins (encoded by the OSBP and ORP1-11 genes) in humans and 7 OSBP 
homology (Osh: Osh1-7) proteins in yeast have been found [85]. Although physiological 
ligands of ORP/Osh proteins had been somewhat mysterious [86-96], structures of Osh 
protein-lipid complexes have provided important insight into their functions as sterol and 
phosphatidylserine (PS) exchange and transfer proteins in vitro and in vivo [97-103]. 
Importantly, while some ORP/Osh proteins bind to sterol lipids and other family members 
bind PS, they are all capable of binding PI4P [104, 105]. The PI4P headgroup interacts with 
residues that are highly conserved in ORP/Osh proteins, suggesting that PI4P is a common 
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ligand of ORP/Osh proteins [104, 105]. Thus, it has been proposed that ORP/Osh proteins 
exchange PI4P for other lipid molecules. Specifically, OSBP [106] and Osh4 [107] are 
proposed to serve as sterol/PI4P exchange proteins in the early secretory pathway and 
ORP5/8 in mammals and Osh6/7 in yeast function as PS/PI4P exchange proteins at ER-PM 
contact sites (PAM) in the control of PI4P and PS levels at the PM [108, 109]. Based on these 
findings, an elegant ‘counter current’ model has been proposed whereby ORP/Osh proteins 
transfer PS or sterol against their gradients in exchange for PI4P at the target membrane [110, 
111]. In line with this idea, additional ORP/Osh proteins show dual sterol/PI4P binding [112-
114].  
 
3.4.2. Must ORP/Osh proteins use counter currents?  
The counter current model for ORP/Osh protein function poses that a newly synthesized 
sterol or PS molecule is selectively removed from the ER and delivered to a target membrane 
organelle in exchange for PI4P continuously synthesized at that site. It is proposed that the 
PI4P-bound ORP/Osh protein must return to the ER where it releases PI4P for hydrolysis by 
an ER-localized phosphatase named Sac1. This elegant model is illustrated in detail by recent 
in vitro studies [107, 109]. However, while ORP/Osh function is essential in all eukaryotic 
cells, work in yeast and mammalian cells has shown that Sac1 activity in the ER is not an 
obligate requirement [115-117]. Even though cells require Sac1 activity for viability [115, 
118, 119], this activity may occur elsewhere than the ER (Golgi compartments, endosomes, 
and even the cytoplasm). This is likely because cells express other Sac1-like activities (such 
as the synaptojanins and even Sac2 in mammalian cells) that localize to other compartments 
in the cell including transport vesicles, Golgi compartments, and endosomes. As such, 
ORP/Osh proteins may present PI4P to Sac1 domain-containing phosphatases at target 
membranes where these enzymes reside.  
Why might subtle distinctions in the ‘counter current’ model be important? First of 
all, they could afford a net gain (+1) of lipid, as the target membrane may retain the PI 
molecule. This may be especially important for membrane expansion during de novo 
biogenesis of a membrane compartment (i.e. peroxisomes and autophagosomes) or for 
transport vesicles undergoing directed transport that undergo fission/fusion reactions and 
mature en route to their final destination. In addition, PI4P-independent and Sac1-
independent ORP/Osh protein function has been demonstrated in vitro and in vivo [107, 117]. 
Moreover, PI(4,5)P2 has been suggested to be a ligand for ORP proteins in vitro, and 
sterol/PI(4,5)P2 exchange has been proposed for mammalian ORP family members in vivo 
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[120-122]. The involvement of ORP5 and ORP8 in mitochondrial function has been also 
reported [123]. Whether PI4P is synthesized at mitochondria and is needed for ORP5/8 
function at mitochondria remains unclear. Thus, alternative modes for ORP/Osh protein 
function may exist in vivo. 
 
3.5. The START domain family 
The steroidogenic acute regulatory protein (StAR)-related lipid transfer (START) 
domain family shares a unique structural module for harboring lipids, named as the START 
domain [124]. The START domain structure bears a hydrophobic pocket that can 
accommodate one lipid molecule [125-130]. In humans, the START domain family consists 
of 15 proteins that fall into six subgroups based on sequence and ligand-binding similarities. 
The STARD1/D3 subgroup and STARD4/D5/D6 subgroup commonly bind cholesterol in 
vitro. The founding member of START domain family members, STARD1/StAR is essential 
for cholesterol transport from the outer to the inner mitochondrial membrane to initiate 
steroid hormone biosynthesis in adrenal and gonad tissues [131]. STARD3/MLN64 is 
ubiquitously expressed and involved in cholesterol transport at ER-endosome contact sites 
[132]. STARD4, STARD5 and STARD6 are composed of only a START domain that binds 
cholesterol, bile acids, or steroids in vitro [133, 134]. In contrast, the STARD2/D7/D10/D11 
subgroup members, STARD2, STARD7 and STARD10 bind PC in vitro [125, 135, 136]. 
Notably, STARD7 maintains mitochondrial PC composition by transferring PC in vivo [137-
139]. STARD11/CERT has been well characterized as a ceramide transfer protein [140]. 
STARD11/CERT transfers ceramide from the ER to the trans-Golgi apparatus where it is 
converted to sphingomyelin. Interestingly, STARD11/CERT weakly binds diacylglycerol in 
vitro [127]. Diacylglycerol is produced by conversion of ceramide to sphingomyelin. 
Therefore, a model of ceramide/diacylglycerol exchange by STARD11/CERT has been 
proposed [18]. Diacylglycerol may be transferred back to the ER by STARD11/CERT to be 
utilized for further rounds of lipid synthesis. 
 
3.6. SMP protein family 
The SMP (synaptotagmin, mitochondrial and lipid binding protein) domain has been 
recently characterized as a lipid-harboring and transfer module. The SMP domain of 
Extended-Synaptotagmin 2 (E-Syt2) has been shown to dimerize forming an extended 
hydrophobic tube that preferentially binds glycerolipids [141], consistent with bioinformatic 
predictions [142, 143]. As E-Syt isoforms and the yeast ortholog tricalbin proteins localize to 
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ER-PM contact sites [144-146], their roles in lipid transfer between ER and the PM are 
expected. In fact, E-Syt proteins can transfer phospholipids and diacylglycerol between 
membrane bilayers with little or no headgroup specificity in vitro. The transfer is 
concentration gradient-dependent and Ca2+-dependent however [147, 148]. In a physiological 
context, it has been proposed that E-Syts transfer excess diacylglycerol from the PM to the 
ER after PI(4,5)P2 hydrolysis by PLC [147]. Another SMP containing protein, TMEM24 
(also known as C2CD2L), concentrates at ER-PM contact sites and transfers phospholipids, 
with a preference for PI, to the PM in response to PLC signaling [149]. 
A SMP domain is also found in the ERMES (ER-mitochondrial encounter structure) 
complex components Mdm12, Mmm1 and Mdm34. The ERMES complex was originally 
identified as a tethering complex that maintains ER-mitochondria contact sites in yeast [150]. 
As the conversion of PS to PC is impaired in ERMES mutants and because mitochondria can 
synthesize PE, a role for the ERMES complex in phospholipid exchange between the ER and 
mitochondria has been proposed. The overall backbone structures of Mdm12 and Mmm1 
resemble that of the SMP domain of E-Syt2, including the presence of hydrophobic cavities 
and an ability to bind phospholipids in vitro [151-153]. Accordingly, the isolated Mmm1-
Mdm12 complex carries out efficient phospholipid transfer between liposomes in vitro [154]. 
Thus the ERMES complex may mediate phospholipid transfer between the ER and 
mitochondria in vivo. Further analyses are needed to fully understand the role of ERMES 
complex in lipid transfer and metabolism in vivo.  
 
3.7. Vps13 and Atg2 
The Vps13 protein family is highly conserved in eukaryotes. Yeast has a single 
VPS13 gene, while the human genome contains four VPS13 genes (VPS13A-D). Mutations 
or perturbations in the expression of VPS13 genes are associated with various human 
disorders [155]. Yet despite their known importance, a molecular function for Vps13 family 
members had been unclear for quite some time. However, an unbiased and comprehensive 
genetic study revealed that the growth defect of yeast ERMES mutants can be bypassed by 
fortuitous gain-of-function mutations in the VPS13 gene [156]. Consequently, it was found 
that yeast Vps13 localizes to membrane contact sites between various organelles including 
ER-mitochondrial contacts [156, 157]. This led to the notion that Vps13 proteins might be 
involved in lipid transfer, and work by the De Camilli and Reinisch groups have recently 
shown that the N-terminal portion of Vps13 is tubular with a hydrophobic cavity that can 
accommodate a large number of lipids. This region of Vps13 efficiently transfers 
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glycerolipids between liposomes in vitro [158]. Interestingly, the N-terminal portion of Vps13 
is similar to the N-terminus of the Atg2 protein [159], implying that Atg2 may transfer lipids 
as well. Indeed, the crystal structure of the N-terminus of Atg2 has been recently resolved and 
its phospholipid transfer activity has been demonstrated in vitro [160, 161]. Surprisingly, a 
Vps13-Atg2 chimera in which the N-terminus of Atg2 is replaced with the N-terminus of 
Vps13 almost fully rescued impaired autophagic activity in atg2 mutant yeast cells. These 
results indicate that the N-terminus of Vps13 and Atg2 share a key function in transferring 
phospholipids [160]. As the Vps13 and Atg2 N-terminal regions have no similarity to any 
characterized lipid transfer module, they are a novel type of LTP. 
 
4. Relationships between phospholipid metabolism and non-vesicular lipid transfer  
As described above, some phospholipid biosynthesis enzymes are enriched at ER 
membrane subdomains. Similarly, some LTPs efficiently target to ER subdomains often 
corresponding to membrane contact sites where they transfer/exchange lipids between 
different organelle membranes. The similarities in their distribution imply functional 
relationships. Next we review recent findings regarding these close connections and discuss 
possible molecular mechanisms linking phospholipid metabolism and transport. 
 
4.1. LTPs enhance the activity of phospholipid metabolizing enzymes 
LTPs may promote lipid metabolism by various mechanisms (Fig. 3). A simple mechanism is 
to increase substrate concentration. As such, LTPs may stimulate lipid metabolism by 
supplying substrates to the membrane domain where enzymes localize (Figs. 3A and 3B). For 
example, it is thought that PITPs including Nir2 and TMEM24 stimulate PM-localized PI 
kinase activity by transferring PI from the ER to the PM [48, 65, 66, 149]. The Class II PITP 
Nir2 is also proposed to transfer PA from the PM to the ER where the ER-localized CDS and 
PIS enzymes convert it to PI. Another mechanism by which LTPs may facilitate lipid 
metabolism is substrate presentation. As some enzymes cannot efficiently use a lipid 
substrate within a lipid bilayer, LTPs may extract and present a lipid to an enzyme in order to 
stimulate its enzymatic reaction (Fig. 3C). This model has been proposed for the Sec14 
protein [75, 77] whereby Sec14-mediated PI/PC exchange promotes interfacial presentation 
of PI to PI 4-kinase to generate PI4P. Based on in vitro results, ORP/Osh proteins have 
similarly been suggested to present PI4P to the Sac1 phosphatase [162], but further studies 
are needed to determine whether this occurs in vivo. As some lipid metabolizing enzymes are 
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activated by lipids other than a substrate [163], LTPs might also enhance enzymatic activities 
by delivering a stimulatory lipid (Fig. 3D). In line with this model, we have recently reported 
that PS and sterol supplied by Osh proteins allosterically activate PI(4,5)P2 synthesis by 
PIP5K [164], which in turn ensures PM organization and integrity [164, 165]. On the other 
hand, some lipid metabolizing enzymes undergo product feedback inhibition [166, 167]. 
Therefore, LTPs might be needed to remove an inhibitory lipid from the membrane where 
enzymes are working to maintain their high enzymatic activity (Fig. 3E). A prime example is 
found in PS synthases (mammalian and yeast) that are inhibited by PS in the ER (product 
feedback inhibition) and the ORP/Osh proteins that transfer newly synthesized PS from the 
ER (ORP5/8 and Osh6/7). Thus, ORP/Osh protein-mediated PS transfer may sustain PS 
synthesis in the ER and stimulate PS-dependent activities at the PM (such as protein kinases, 
PIP5K, and Rho-family small GTPases) [164, 168, 169]. Indeed, inactivation of the yeast 
Osh proteins leads to a significant reduction in cellular PS levels as well as decreased PS in 
the cytoplasmic leaflet of the PM [164]. 
 
4.2. Phospholipid synthesis facilitates loading of lipid molecules to LTPs. 
Are there other reasons why phospholipid biosynthesis enzymes are 
compartmentalized within the ER? Several studies have proposed that enrichment of 
phospholipid biosynthesis enzymes might facilitate non-vesicular lipid transfer at membrane 
contact sites (Figs. 4 and 5). In 1991, Dr. Jean E. Vance reported that newly synthesized PS 
and PE are efficiently transferred between ER microsomes and mitochondria isolated from rat 
liver [170]. Similarly, another group has shown that newly synthesized PS is rapidly 
translocated from the ER to the mitochondria and metabolized into PE in permeabilized yeast 
cells [171]. A more recent study has directly demonstrated the stimulatory effect of localized 
PS synthesis on lipid transfer activity. Artificially targeting E. coli PS synthase, a peripheral 
membrane protein that has no homology to yeast or mammalian PS synthases, to ER-
mitochondria contacts (MAM) promotes PS transport from the ER membrane to 
mitochondria in yeast [166].  
 How does phospholipid synthesis enhance non-vesicular lipid exchange and transfer? 
Lipid transport by LTPs is divided into several different steps (Fig. 2). First, LTPs must dock 
to donor membranes and load a lipid ligand (Steps 1-3 in Fig. 2). One possibility is that 
localized enrichment of lipid biosynthesis enzymes can increase the local concentration of 
lipid ligands. This may be especially important, given that lipids can be flipped to the luminal 
side of the ER membrane (by either spontaneous or flippase-induced transbilayer 
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movements) thereby effectively reducing their amounts on the cytoplasmic leaflet. 
Compartmentalized lipid biosynthesis within ER subdomains may establish localized 
concentration gradients of newly synthesized lipids for LTP capture (Fig. 4A and 4B). As 
phospholipid remodeling mainly occurs in the ER membranes, we also have to consider 
changes in fatty acid composition of ER phospholipids. The fatty acid composition of nascent 
lipids might be preferred by LTPs compared to lipids with prolonged ER retention times that 
are more likely to have undergone acyl chain remodeling (Fig. 4C). In support of this idea, 
the Osh6 protein preferentially transfers saturated PS in vitro [109]. It will be important to 
examine whether alterations in phospholipid remodeling pathways affect lipid exchange and 
transfer in vivo. Another possibility is a regulatory effect of lipid metabolism on LTP 
functions. Lipid metabolizing enzymes might generate stimulatory lipids (Fig. 4D) or 
consume some inhibitory lipids for LTP docking/loading steps (Fig. 4E). Indeed, given that 
PI3P stimulates Atg2-dependent lipid transfer in vitro [160], it is reasonable to consider that 
PI3P synthesis might enhance Atg2-dependent lipid transfer in vivo. In addition, at least two 
studies have proposed a key role for ER-shaping factors in phospholipid metabolism and LTP 
function [30, 172]. Phospholipid metabolic enzymes and LTPs might share similar 
preferences for membrane curvature such as ER tubules (Fig. 4F).  
 
4.3. Phospholipid metabolism and unloading of lipid molecules from LTPs 
 After lipid ligand loading, LTPs target and dock to acceptor membranes and then 
unload the ligand (Steps 5-7 in Fig. 2). As lipid metabolism may consume a lipid ligand and 
reduce its local concentration, this may effectively prevent re-extraction of the transferred 
lipid and thus promote directional transfer (Figs. 5A and 5B). Likewise, some enzymes may 
generate a competitive ligand for LTPs and facilitate an exchange of lipid ligands in the same 
membrane (Fig. 5C). A good example is Class II PITPs. After Nir2 and Drosophila RdgB 
transfer PA to the ER, the PA is converted into PI by CDS and PIS in the ER membrane 
(ligand consumption, Fig. 5B). As newly synthesized PI is also a ligand for Class II PITPs 
with a higher affinity compared to PA [66], PA is released and instead PI is loaded 
(competitor ligand, Fig. 5C). Another example is ORP5/8 in mammals and Osh6/7 in yeast. 
These ORP/Osh proteins extract PI4P from the PM and bring it back toward the ER for 
hydrolysis by Sac1 in the ER membrane (ligand consumption, Fig. 5B). The ORP proteins 
then in turn extract newly synthesized PS in the ER (competitor ligand, Fig. 5C). Although 
the binding affinity of PS to ORP proteins is less than that of PI4P [109], the concentration of 
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PI4P is thought to be extremely low in the ER due to Sac1. Alternatively, it is also possible 
that lipid metabolism generates some stimulatory lipids for unloading ligands (Fig. 5D). For 
example, PI(4,5)P2 is thought to stimulate sterol release from Osh proteins [99, 173] and 
STARD family members [174]. 
 
 
 
5. Future questions 
Although the significance of ER subdomains in lipid metabolism and transport was 
first proposed almost 30 years ago, the past few years have seen tremendous advances in our 
knowledge of lipid dynamics. Recent studies have identified physiological ligands of LTPs 
and presented insightful models for non-vesicular lipid transport machinery. In particular, 
structural analyses have facilitated a better understanding of how LTPs harbor and transfer 
lipids. Of note, some LTPs such as the E-Syt, Vps13, and Atg2 proteins not only serve as 
lipid carriers but also as tethers that form ER-organelle contact sites in vivo, further 
suggesting that lipid exchange and transfer events are coupled with membrane contact site 
formation. While these advances have pushed the field forward, many key issues remain to be 
clarified. How the directionality of lipid exchange and transfer is regulated is still a big 
mystery in this field. Some LTPs move lipids from high to low concentration, while other 
LTPs transfer them against their concentration gradients in vivo. Thus another major question 
involves how various LTPs activities are coordinated to result in net membrane lipid gain or 
changes in membrane lipid composition as needed. An additional point is that in vitro lipid 
transport by LTPs is not as high as predicted in vivo. It has been argued that there is a big gap 
between in vitro lipid transport rates and lipid demand in vivo [175-177]. These discrepancies 
might be explained by the contribution of yet uncharacterized factors in the 
loading/unloading steps of LTPs. Possibly, lipid inter-conversion and metabolism may play 
important roles in the rapid transfer rates observed in vivo. To address this issue, novel 
methods to detect and evaluate lipid movements in vivo are needed. Finally, unlike typical 
LTPs, some SMP domain proteins, Vps13 family, and Atg2 family members have a capacity 
to bind multiple lipids with little or no headgroup specificity in vitro. Therefore, it is natural 
to consider that these proteins need to be coupled with lipid metabolism enzymes to achieve 
selective lipid transport in vivo. Important questions in lipid metabolism and transport will 
undoubtedly continue to be a major focus of cell biology research. 
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Figure Legends 
 
Figure 1. Phospholipid biosynthesis pathways 
Phospholipid biosynthesis pathways in yeast and mammalian cells. Yeast-specific, 
mammalian-specific, and common pathways are shown in blue, red and black lines 
respectively. PC, phosphatidylcholine; PE, phosphatidylethanolamine; PS, 
phosphatidylserine; PI, phosphatidylinositol; PG, phosphatidylglycerol; PA, phosphatidic 
acid; lysoPA, lysophosphatidic acid; DAG, diacylglycerol; TAG, triacylglycerol; CDP-DAG, 
cytidine diphosphate-diacylglycerol; GPAT, glycerol-3-phosphate acyltransferase; LPAAT, 
lysoPA acyltransferase; PAP, phosphatidate phosphatase; DGAT, acyl-CoA:diacylglycerol 
acyltransferase; CDS, CDP-DAG synthase; PIS, phosphatidylinositol synthase; PSS, 
phosphatidylserine synthase; PSD, phosphatidylserine decarboxylase; PEMT, 
phosphatidylethanolamine N-methyltransferase; P-Ch, phosphocholine; P-Et, 
phosphoethanolamine; CDP-Ch, CDP-choline; CDP-Et, CDP-ethanolamine; CPT, 
cholinephosphotransferase; EPT, ethanolaminephosphotransferase; CEPT, 
choline/ethanolaminephosphotransferase. 
 
Figure 2. Non-vesicular lipid transfer by box-type LTPs 
[Top panel] Sequential lipid transfer by box-type lipid transfer proteins (LTPs), such as PITPs, 
ORP/Osh proteins, CRAL-TRIO family members and STARD proteins, is divided into 8 
distinct steps. (1) A LTP docks to a donor membrane. (2) The LTP extracts a lipid ligand from 
the donor membrane. (3) The LTP detaches from the donor membrane and its lid closes. (4) 
The LTP is targeted toward an acceptor membrane. (5) The LTP docks to the acceptor 
membrane. (6) The lid of the LTP opens. (7) The lipid ligand is released and transferred to the 
acceptor membrane. (8) The LTP detaches from the acceptor membrane.  
[Bottom panel] A cartoon showing membrane contact sites in cells. The endoplasmic 
reticulum (ER) is associated with other organelle membranes, such as mitochondria, the 
plasma membrane (PM), the trans-Golgi network (TGN), endosomes (End), and lipid 
droplets (LD). PAM, PM-associated membranes; MAM, mitochondria-associated membranes. 
Please see additional review articles in this issue for more information on ER-endosome and 
ER-lipid droplet contacts. 
 
Figure 3. Models for stimulation of phospholipid metabolism by LTPs 
(A) Basal enzymatic conversion of a lipid substrate to a new lipid product in the absence of 
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lipid exchange and transfer. (B-E) LTPs can stimulate an enzyme by supplying substrates to 
membranes where an enzyme is localized (B), by directly presenting substrates to an enzyme 
(C), by delivering stimulatory lipids to membranes where an enzyme is localized (D), and by 
removing inhibitory lipids from membranes where an enzyme is localized (E). 
 
Figure 4. Models for stimulation of LTP loading by phospholipid metabolism. 
(A) Basal LTP lipid extraction activity in the absence of phospholipid metabolism. (B) An 
enzyme generates newly synthesized lipids and increases their local concentration to facilitate 
the loading of lipid ligands to LTPs. (C) An enzyme modifies the fatty acid compositions of 
ligands and increases amount of lipids containing fatty acid species preferred by LTPs as a 
ligand. (D) An enzyme generates stimulatory lipids and enhances membrane association of 
LTPs. (E) An enzyme consumes competing ligands and to facilitate loading of ligands to 
LTPs. (F) An enzyme and LTPs might have a similar preference for membrane curvature. 
Increased membrane curvature is proposed to decrease the energy barrier for lipid extraction. 
 
Figure 5. Models for stimulation of LTP unloading by phospholipid metabolizing 
enzymes. 
(A) Basal LTP unloading of lipid ligands to an acceptor membrane in the absence of an 
enzyme. (B) An enzyme consumes ligands in the acceptor membrane and reduces their local 
concentration, which can facilitate unloading steps of ligands from LTPs. (C) An enzyme 
generates competing ligands and increases their local concentration, which can prevent re-
extraction of transferred ligands by LTPs. (D) An enzyme generates lipid stimulators and 
enhances membrane association of LTPs, which results in an enhancement of unloading step 
of ligands from LTPs. 
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Highlights 
 Lipid metabolism is sub-compartmentalized in the endoplasmic 
reticulum. 
 
 The endoplasmic reticulum forms membrane contact sites with 
numerous organelles in the cell. 
 
 Lipid exchange and transport are facilitated by lipid transfer protein 
activities at organelle contacts. 
 
 Lipid metabolism and transport pathways undergo mutual cross talk. 
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